NCT05966376

Brief Summary

Comparison of PreludeSYNC distal and Modified Terumo Radial Band in patients with distal radial approach.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
482

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2022

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

April 5, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

July 28, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

September 21, 2023

Status Verified

September 1, 2023

Enrollment Period

1.7 years

First QC Date

April 5, 2023

Last Update Submit

September 18, 2023

Conditions

Keywords

Distal Radial Artery AccessPreludeSYNC distalTerumo Radial Band

Outcome Measures

Primary Outcomes (1)

  • To compare the incidence of proximal radial artery occlusion assessed by ultrasound and the incidence of hematoma/bleeding assessed clinically by EASY scale of PreludeSYNC distal versus Modified Terumo Radial Band in distal radial approach.

    At 24 hours after the procedure, patients will be evaluated by interrogation, physical exam and ultrasonography. The absence of Doppler flow in the proximal radial artery at wrist level will define the occlusion of the radial artery. The EASY scale will be used to classify the severity of the hematoma in degrees from I to V according to the extension.

    24 hours after the procedure. Patients with radial occlusion at 24 hours will be follow at 30 days.

Secondary Outcomes (6)

  • Incidence of distal and proximal radial artery occlusion at 24 hours after the procedure.

    24 hours after the procedure.

  • Radial arterial patency at 30 days in patients with obstruction at 24 hours.

    30 days after the procedure

  • Incidence of hematoma at the approach site.

    24 hours after the procedure.

  • Bleeding at the access site.

    24 hours after the procedure.

  • Neurological sequelae.

    24 hours after the procedure.

  • +1 more secondary outcomes

Study Arms (2)

Modified Terumo Radial Band

EXPERIMENTAL

A standard hemostatic device used for proximal radial approach. The hard plastic component is removed to achieve better attachment in the distal radial approach. * Clean and dry the puncture site. * The introducer is withdrawn 2 cm. * Place the device on the patient's hand depending on the approach side. * Terumo logo is positioned toward the little finger side. * The green mark is positioned 1 cm proximal to the puncture site. * The bands are adjusted and fixed around the wrist. * The Terumo syringe is filled with 15 ml of air. * The balloon of the device is slowly inflated through the valve while the introducer is slowly withdrawn simultaneously. * Once the introducer is completely withdrawn, the balloon continues to be inflated until the absence of bleeding is verified. * Once hemostasis is achieved, the patient must be able to move his fingers and wrist without bleeding. If bleeding is observed, the balloon is inflated to achieve adequate hemostasis.

Device: Hemostatic device for distal radial approach.

PreludeSYNC distal

ACTIVE COMPARATOR

A specific hemostatic device, designed for distal radial approach. * Clean and dry the puncture site. * Selection and preparation of the PreludeSYNC distal device according to the approach side. * The introducer is withdrawn 2cm. * The hemostasis device is placed on the patient's hand. * Bands position: 1) little finger side; 2) thumb side; 3) between the thumb and the index finger. * The circular mark of the balloon is positioned 1cm proximal to the puncture site. * Bands are adjusted and fixed. * The syringe is filled with 10 ml of air. * The balloon of the device is slowly inflated while the introducer is slowly withdrawn simultaneously. * Once the introducer is completely withdrawn, the balloon continues to be inflated until the absence of bleeding is verified. * Once hemostasis is achieved, the patient must be able to move his fingers and wrist without bleeding. If bleeding is observed, the balloon should be inflated to achieve adequate hemostasis.

Device: Hemostatic device for distal radial approach.

Interventions

Hemostasis after distal radial approach is done with one of two devices, one of them is designed specifically for the distal radial approach; the other is not but a modified technique with the last one could be helpful.

Also known as: PreludeSYNC distal, Terumo Radial Band
Modified Terumo Radial BandPreludeSYNC distal

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Coronary artery disease including chronic coronary syndrome or acute coronary syndrome.
  • Cardiovascular disease that requires coronary angiography in its approach.

You may not qualify if:

  • Cardiogenic shock.
  • Lesions in venous or arterial hemoducts.
  • Impossibility to provide informed consent.
  • Chronic kidney disease on hemodialysis through arteriovenous fistula at the same site where the approach is planned.
  • Severe chronic renal failure (GFR less than 30 ml/min/m2)
  • Patients diagnosed with cancer.
  • Patient with rheumatological and hematological pro-thrombotic disorders.
  • Non-hydrophilic radial introducer.
  • Failed cannulation of the radial artery with an introducer.
  • Successful trans-radial access that is crossed over to the femoral approach.
  • Patients with an interventional procedure using a radial approach in the previous 30 days.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Nacional de Cardiologia Ignacio Chávez

Mexico City, 14080, Mexico

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Interventional Cardiology

Study Record Dates

First Submitted

April 5, 2023

First Posted

July 28, 2023

Study Start

February 1, 2022

Primary Completion

November 1, 2023

Study Completion

December 1, 2023

Last Updated

September 21, 2023

Record last verified: 2023-09

Locations